Cipla P/E Ratio
Cipla P/E ratio. Cipla (CIPLA) P/E ratio is 32.04 (High), EPS (TTM) ₹48.03, current price ₹1330.90 on NSE vs historical average P/E of 25.55 (87.5th percentile) — Very High - High growth expectations or significantly overvalued. Also explore CIPLA stock price history to track price trends across different timeframes.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
CIPLA P/E Ratio — Valuation Signal & Historical Context
Cipla P/E 32.04 vs historical average 25.55, range 17.15–36.79 — signal: Overvalued. Examine Cipla quarterly financials for recent quarterly revenue, profit and EPS trends.
- Stock appears overvalued with PE of 32.04, suggesting caution for new investments
- Current PE is 25.4% above historical average
- Trading at discount to sector average PE of 54.94
Cipla P/E Ratio Historical Trend
CIPLA annual price-to-earnings ratio — 8 years, EPS and year-end price. Current P/E 32.04 vs historical average 25.55. For live price, revenue and the complete fundamental profile, see Cipla share price today.
CIPLA Historical P/E Ratio — EPS, Year-End Price & Valuation
Cipla annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 27.16 | 56.3 | ₹1529.10 | NSE | High |
| 2024 | 20.25 | 61.79 | ₹1251.00 | NSE | Moderate |
| 2023 | 23.31 | 45.94 | ₹1070.95 | NSE | Moderate |
| 2022 | 28.46 | 32.7 | ₹930.50 | NSE | High |
| 2021 | 25.96 | 31.84 | ₹826.60 | NSE | High |
| 2020 | 17.15 | 27.75 | ₹475.90 | NSE | Moderate |
| 2019 | 25.28 | 20.69 | ₹523.05 | NSE | High |
| 2018 | 36.79 | 16.62 | ₹611.50 | NSE | High |
CIPLA vs Healthcare Peers — P/E Ratio Comparison
Cipla P/E 32.04 vs Healthcare average 54.94, median 31.69 — range 2.02–722.21.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.02 | ₹60 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.33 | ₹55 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.86 | ₹6,006 | Low |
| Dipna Pharmachem | DPL | 3.97 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 5.05 | ₹65 | Low |
| Royal Sense | ROYAL | 5.39 | ₹40 | Low |
| Kabra Drugs | KABRADG | 5.47 | ₹41 | Low |
| GKB Ophthalmics | GKB | 5.85 | ₹32 | Low |
| Colinz Laboratories | COLINZ | 6.31 | ₹18 | Low |